
Abbott Just Bet $21 Billion on Advanced Cancer Testing – Why It’s a Good Bet
The $21 Billion Wake-Up Call Advanced Cancer Testing Is Eating Standard Cancer Care When a

The $21 Billion Wake-Up Call Advanced Cancer Testing Is Eating Standard Cancer Care When a

Specicare is a leading biomedical services company dedicated to advancing personalized medicine and clinical research. The company offers a comprehensive suite of services critical to both patient care and scientific discovery. These services include the meticulous cryopreservation and storage of tissue and blood samples, specialized clinical trials management and matching to connect patients with appropriate studies, and detailed electronic medical record summaries to streamline data. Furthermore, Specicare supports therapeutic development through Tissue Licensing, ex-vivo drug panel testing for individualized treatment strategies, and advanced genomics testing to unlock genetic insights.

A Modern Approach to Your Cancer Biopsy – Why Cryopreserving Your Tumor Tissue is a